Testosterone therapy may actually inhibit the growth of aggressive prostate cancer.
Oncology
Advertisement
Paclical/Apealea found to be non-inferior to current treatment for patients with epithelial ovarian cancer.
Advertisement
Top news of the day from across the health care landscape.
Blincyto granted priority status to treat a form of acute lymphoblastic leukemia.
Survivors of pediatric cancer observed to have similar health-related quality of life as older adults.
Personalized cancer treatments need to account for conditions such as heart or lung diseases.
Advertisement
New research shines light on cancer drug resistance.
Numerical simulations show the long-term success of immunotherapy is dependent on random fluctuations.
Cancer tumors are unable to grow larger than 2 millimeters unless angiogenesis is present.
Top news of the day from across the health care landscape.
Advertisement
Immune response that attacks tumors may significantly improve progression-free survival.
Proliferation assays are typically used to see how cancer cells respond to a drug, but this method may not be the most effective.
Top news of the day from across the health care landscape.
The small molecule drug, SI-2, found to improve cancer treatment in mouse models.
TAT-CaM could potentially have a multitude of applications, including cancer treatment.
The cost of oral cancer drugs spiked six-fold within the last 14 years.
Women with proliferating cells within mammary epithelium cells significantly more likely to develop breast cancer.
Ability to produce epiregulin may influence cancer development.
Ability to produce epiregulin may influence cancer development.
The use of microparticles and mesenchymal stem cells has shown potential to treat prostate cancer.
Obese people found to be at greater risk for developing colon cancer.
Infertility and breast density may impact the risk of cancer.
Infertility and breast density may impact the risk of cancer.
Targeted approach may lead to improved treatments for cancer.
JAK2 could potentially cause treatment resistance in TNBC.
Prognostic model provides simple and accurate clinical description for each HCC patient.
JAK2 could potentially cause treatment resistance in TNBC.
Top news of the day from across the health care landscape.
Vitamin D deficiency has been associated with different cancer types, such as breast, lung, colon, and bladder cancers.
Cortistatin A is a natural product isolated from an Indonesian marine sponge with potent anti-angiogenic activity at low dosages.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Can Close the Opioid Addiction Care Gap
2
FDA Approval Signals Broader Recognition of Sexual Health in Aging Women
3
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
4
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
5
